Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.

[1]  D. Roden.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[2]  F. Segura,et al.  QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. , 2003, The American journal of cardiology.

[3]  H. Thaler,et al.  QTc interval prolongation associated with intravenous methadone , 2003, Pain.

[4]  Bridget A. Martell,et al.  The impact of methadone induction on cardiac conduction in opiate users. , 2003, Annals of internal medicine.

[5]  P. Walker,et al.  High dose methadone and ventricular arrhythmias: a report of three cases , 2003, Pain.

[6]  P. Mehler,et al.  Dose‐Related Effects of Methadone on QT Prolongation in a Series of Patients with Torsade de Pointes , 2003, Pharmacotherapy.

[7]  P. Mehler,et al.  Torsade de Pointes Associated with Very-High-Dose Methadone , 2002, Annals of Internal Medicine.

[8]  Mellar P. Davis,et al.  Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration , 2001, Supportive Care in Cancer.

[9]  J. Camm,et al.  Risk of torsades de pointes with non-cardiac drugs , 2000, BMJ : British Medical Journal.

[10]  C. Brunelli,et al.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Gorman,et al.  The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord , 1997, Neuroscience Letters.